Hypertension, fluid overload and micro inflammation are associated with left ventricular hypertrophy in maintenance hemodialysis patients

References

• Bossola M, Tazza L, Vulpio C, Luciani G. Is regression of left ventricular hypertrophy in maintenance hemodialysis patients possible? Semin Dial. 2008;20(5):422–430
   Google Scholar
• Paoletti E, Specchia C, Di Maio G. The worsening of left ventricular hypertrophy is the strongest predictor of sudden cardiac death in hemodialysis patients: a 10 year survey. Nephrol Dial Transplant. 2004;19(7):1829–1834
   PubMed Web of Science ®Google Scholar
• Patel RK, Oliver S, Mark PB, et al. Determinants of left ventricular mass and hypertrophy in hemodialysis patients assessed by cardiac magnetic resonance imaging. Clin J Am Soc Nephrol. 2009;4(9):1477–1483
   PubMed Web of Science ®Google Scholar
• Foley RN, Curtis BM, Randell EW, Parfrey PS. Left ventricular hypertrophy in new hemodialysis patients without symptomatic cardiac disease. Clin J Am Soc Nephrol. 2010;5(5):805–813
   PubMed Web of Science ®Google Scholar
• Daugirdas JT. Second generation logarithmic estimates of single-pool variable volume Kt/V: an analysis of error. J Am Soc Nephrol. 1993;4:1205–1213
   PubMed Web of Science ®Google Scholar
• Devereux RB, Alonso DR, Lutas EM, et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol. 1986;57:450–458
   PubMed Web of Science ®Google Scholar
• De Simone G, Daniels SR, Devereux RB. Left ventricular mass and body size in normotensive children and adults. J Am Coll Cardiol. 1992;20:1251–1260
   PubMed Web of Science ®Google Scholar
• Kadiri Mel M, Nechba RB, Zajjari YR, et al. Association of adequate dialysis parameters with left ventricular hypertrophy in hemodialysis patients. Saudi J Kidney Dis Transpl. 2011;22(6):1133–1141
   PubMedGoogle Scholar
• Cao X, Zou J, Teng J, et al. BMI, spKt/V, and SBP but Not DBP are related to LVH in Chinese maintenance hemodialysis patients. Ren Fail. 2011;33(3):269–275
   PubMed Web of Science ®Google Scholar
• Takeda A, Toda T, Iwamoto H, Watanabe K, Matsui N. Long-term evolution and changing associations of left ventricular hypertrophy after starting hemodialysis. Nephron Clin Pract. 2008;110(2):c126–c132
   Google Scholar
• Wang AY, Lai KN. Use of cardiac biomarkers in end-stage renal disease. J Am Soc Nephrol. 2008;19(9):1643–1652
   PubMed Web of Science ®Google Scholar
• Choi SY, Lee JE, Jang EH, et al. Association between changes in N-terminal pro-brain natriuretic peptide levels and changes in left ventricular mass index in stable hemodialysis patients. Nephron Clin Pract. 2008;110(2):c93–c100
   Google Scholar
• Sommerer C, Beimler J, Schwenger V, et al. Cardiac biomarkers and survival in hemodialysis patients. Eur J Clin Invest. 2007;37(5):350–356
   PubMed Web of Science ®Google Scholar
• Mallamaci F, Zoccali C, Parlongo S, et al. Troponin is related to left ventricular mass and predicts all-cause and cardiovascular mortality in hemodialysis patients. Am J Kidney Dis. 2002;40:68–75
   PubMed Web of Science ®Google Scholar
• van der Sande FM, Kooman JP, Leunissen KM. The predictive value of C-reactive protein in end-stage renal disease: is it clinically significant? Blood Purif. 2006;24(4):335–341
   PubMed Web of Science ®Google Scholar
• Dervisoglu E, Kozdag G, Etiler N, Kalender B. Association of glomerular filtration rate and inflammation with left ventricular hypertrophy in chronic kidney disease patients. Hippokratia. 2012;16(2):137–142
   PubMed Web of Science ®Google Scholar
• Kim BS, Jeon DS, Shin MJ, et al. Persistent elevation of C-reactive protein may predict cardiac hypertrophy and dysfunction in patients maintained on hemodialysis. Am J Nephrol. 2005;25(3):189–195
   PubMed Web of Science ®Google Scholar
• Park CW, Shin YS, Kim CM, et al. Increased C-reactive protein following hemodialysis predicts cardiac hypertrophy in chronic hemodialysis patients. Am J Kidney Dis. 2002;40(6):1230–1239
   PubMed Web of Science ®Google Scholar
• Monfared A, Salari A, Kazemnezhad E, et al. Association of left ventricular hypertrophy with high-sensitive C-reactive protein in hemodialysis patients. Int Urol Nephrol. 2013 . [Epub ahead of print]. doi: 10.1007/s11255-012-0375-x
   PubMed Web of Science ®Google Scholar
• Mack WJ, LaBree L, Liu C, Selzer RH, Hodis HN. Correlations between measures of atherosclerosis change using carotid ultrasonography and coronary angiography. Atherosclerosis. 2000;150(2):371–379
   PubMed Web of Science ®Google Scholar
• Kaysen GA. Association between inflammation and malnutrition as risk factors of cardiovascular disease. Blood Purif. 2006;24(1):51–55
   PubMed Web of Science ®Google Scholar
• Trimarchi H, Muryan A, Campolo-Girard V, et al. Elevated pro-brain natriuretic peptide, troponin T and malnutrition inflammatory score in chronic hemodialysis patients with overt cardiovascular disease. Nephron Clin Pract. 2011;117(3):c198–c205
   Google Scholar
• Al-Hilali N, Hussain N, Ataia AI, et al. Hypertension and hyperparathyroidism are associated with left ventricular hypertrophy in patients on hemodialysis. Indian J Nephrol. 2009;19(4):153–157
   PubMedGoogle Scholar
• Alvestrand A, Ledebo I, Hagerman I, et al. Left ventricular hypertrophy in incident dialysis patients randomized to treatment with hemofiltration or hemodialysis: results from the ProFil study. Blood Purif. 2011;32(1):21–29
   PubMed Web of Science ®Google Scholar
• Schiffl H, Lang SM, Fischer R. Effects of high efficiency post-dilution on-line hemodiafiltration or conventional hemodialysis on residual renal function and left ventricular hypertrophy. Int Urol Nephrol. 2012 . [Epub ahead of print]. doi: 10.1007/s11255-012-0336-4
   Web of Science ®Google Scholar